Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of FT 2102 in Participants With Advanced Solid Tumors and Gliomas With an IDH1 Mutation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03684811
Recruitment Status : Active, not recruiting
First Posted : September 26, 2018
Last Update Posted : March 29, 2021
Information provided by (Responsible Party):
Forma Therapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 1, 2021
Estimated Study Completion Date : April 1, 2022